400
Participants
Start Date
May 23, 2024
Primary Completion Date
December 4, 2034
Study Completion Date
December 4, 2034
Bomedemstat
10, 15, 20, and 50 mg oral capsules
ACTIVE_NOT_RECRUITING
Aotearoa Clinical Trials ( Site 1400), Auckland
RECRUITING
Royal Prince Alfred Hospital ( Site 1003), Camperdown
RECRUITING
Royal North Shore Hospital ( Site 1001), St Leonards
RECRUITING
Monash Health ( Site 1004), Clayton
RECRUITING
Gold Coast University Hospital-Cancer and Blood Disorders Clinical Trial Team ( Site 1002), Southport
RECRUITING
Sunshine Coast Hematology and Oncology Clinic ( Site 1006), Buderim
RECRUITING
Royal Adelaide Hospital-Haematology Clinical Trials Unit ( Site 1000), Adelaide
RECRUITING
Azienda Ospedaliero-Universitaria SS. Antonio e Biagio e Cesare Arrigo ( Site 2703), Alessandria
RECRUITING
UPMC Hillman Cancer Center ( Site 6004), Pittsburgh
RECRUITING
Ospedale di Circolo e Fondazione Macchi Varese ( Site 2701), Varese
RECRUITING
DUHS Duke Blood Cancer Center ( Site 6005), Durham
RECRUITING
IRCCS Azienda Ospedaliero-Universitaria di Bologna, Policlinico di Sant'Orsola ( Site 2702), Bologna
RECRUITING
The James Cancer Hospital and Solove Research Institute at The Ohio State University Comprehensive C ( Site 6007), Columbus
RECRUITING
University of Michigan ( Site 6000), Ann Arbor
RECRUITING
Azienda Ospedaliera Universitaria Careggi ( Site 2700), Florence
ACTIVE_NOT_RECRUITING
Queen Mary Hospital ( Site 1601), Hksar
ACTIVE_NOT_RECRUITING
North Shore Hospital-Department of Haematology ( Site 1401), Auckland
RECRUITING
Imperial College Healthcare NHS Trust - Hammersmith Hospital ( Site 3402), London
RECRUITING
Boston Pilgrim Hospital ( Site 3403), Boston
RECRUITING
University College London Hospital ( Site 3400), London
RECRUITING
Guy's & St Thomas' NHS Foundation Trust ( Site 3401), London
Merck Sharp & Dohme LLC
INDUSTRY